Literature DB >> 1702519

Genotoxicity and cell proliferative activity of omeprazole in rat stomach mucosa.

C Furihata1, K Hirose, T Matsushima.   

Abstract

Induction of unscheduled DNA synthesis (UDS) as a marker of genotoxicity and induction of ornithine decarboxylase (ODC) activity as a marker of cell proliferative activity by omeprazole were determined in the glandular stomach mucosa of male F344 rats after oral administration. Commercial enteric-coated omeprazole (Losec) at doses of 30 and 100 mg/kg body weight induced a dose-dependent increase in UDS but not replicative DNA synthesis in the pyloric mucosa of rat stomach 4 h after its administration. Dose-dependent significant induction of ODC activity was observed in fundic and pyloric mucosa with a maximum 8 h after administration of omeprazole at doses of 37.5-100 mg/kg body weight. These results show that omeprazole has genotoxicity and cell proliferative activity in the rat glandular stomach mucosa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702519     DOI: 10.1016/0165-7992(91)90109-h

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Omeprazole.

Authors: 
Journal:  BMJ       Date:  1991-11-09

2.  Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.

Authors:  M L Cloud; W W Offen
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

3.  Evaluation of a proposed technique to assess unscheduled DNA synthesis and genotoxicity.

Authors:  R A Goodlad; C Y Lee; M R Alison; C E Sarraf; M A Ghatei; S R Bloom; N A Wright
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

Review 4.  Acid suppression and claims of genotoxicity. What have we learned?

Authors:  R A Goodlad
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 5.  Acid suppression and gastric mucosal cell biology.

Authors:  G Delle Fave; H Helander; S Holt; I M Modlin; R Powers; E Solcia; A Soll; Y Tielemans; N A Wright
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 6.  Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.

Authors:  W Creutzfeldt
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

7.  Omeprazole inhibits growth of cancer cell line of colonic origin.

Authors:  M Tobi; S Chintalapani; R Goo; B Maliakkal; J Reddy; M Lundqvist; K Oberg; G Luk
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

8.  Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis.

Authors:  Ana Maria Oliveira Ferreira da Mata; Marcia Fernanda Correia Jardim Paz; Ag-Anne Pereira Melo de Menezes; Antonielly Campinho Dos Reis; Bruna da Silva Souza; Carlos Dimas de Carvalho Sousa; Sônia Alves Machado; Thiago Soares Gondim Medeiros; Chandan Sarkar; Muhammad Torequl Islam; Javad Sharifi-Rad; Sevgi Durna Daştan; Mohammed M Alshehri; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Cancer Cell Int       Date:  2022-04-18       Impact factor: 6.429

Review 9.  Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer.

Authors:  Márcia Fernanda Correia Jardim Paz; Marcus Vinícius Oliveira Barros de Alencar; Rodrigo Maciel Paulino de Lima; André Luiz Pinho Sobral; Glauto Tuquarre Melo do Nascimento; Cristiane Amaral Dos Reis; Maria do Perpetuo Socorro de Sousa Coêlho; Maria Luísa Lima Barreto do Nascimento; Antonio Luiz Gomes Júnior; Kátia da Conceição Machado; Ag-Anne Pereira Melo de Menezes; Rosália Maria Torres de Lima; José Williams Gomes de Oliveira Filho; Ana Carolina Soares Dias; Antonielly Campinho Dos Reis; Ana Maria Oliveira Ferreira da Mata; Sônia Alves Machado; Carlos Dimas de Carvalho Sousa; Felipe Cavalcanti Carneiro da Silva; Muhammad Torequl Islam; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Oxid Med Cell Longev       Date:  2020-03-28       Impact factor: 6.543

10.  Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.

Authors:  Chie Furihata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2021       Impact factor: 3.493

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.